AGF Investments Inc’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$73.5M Sell
2,006,840
-355,410
-15% -$15.8M 0.69% 44
2022
Q2
$101M Buy
2,362,250
+43,910
+2% +$2.09M 0.89% 36
2022
Q1
$125M Buy
2,318,340
+582,140
+34% +$33.9M 0.93% 32
2021
Q4
$125M Buy
1,736,200
+791,460
+84% +$49.6M 0.9% 29
2021
Q3
$53.8M Sell
944,740
-219,180
-19% -$13.3M 0.41% 88
2021
Q2
$75.7M Sell
1,163,920
-160,770
-12% -$10.1M 0.57% 61
2021
Q1
$78.9M Buy
1,324,690
+434,360
+49% +$23.7M 0.62% 54
2020
Q4
$42M Buy
890,330
+266,770
+43% +$11.2M 0.36% 98
2020
Q3
$20.7M Buy
623,560
+47,650
+8% +$1.64M 0.21% 137
2020
Q2
$18.6M Buy
575,910
+203,170
+55% +$5.54M 0.2% 138
2020
Q1
$8.95M Buy
+372,740
New +$10.7M 0.11% 164
2017
Q2
Sell
-1,959,230
Closed -$25.1M 433
2017
Q1
$25.1M Buy
1,959,230
+399,230
+26% +$4.69M 0.27% 106
2016
Q4
$16.5M Buy
+1,560,000
New +$15.8M 0.19% 143

Other funds holding LRCX

AGF Investments Inc's LRCX Position: Q3 2022 in Review

AGF Investments Inc reduced its Lam Research (LRCX) stake by 15% in Q3 2022, selling an estimated $15.8M and leaving 2,006,840 shares worth $73.5M. The position accounts for 0.69% of the portfolio, ranked #44.

AGF Investments Inc first reported a position in LRCX in Q4 2016 and has held it in 13 quarters since. The position peaked at $125M in Q4 2021. 1,271 funds tracked by Wall St. Rank hold LRCX as of Q3 2022.

  • AGF Investments Inc held 2,006,840 shares of Lam Research worth $73.5M as of Q3 2022.
  • AGF Investments Inc sold 355,410 Lam Research shares in Q3 2022, an estimated $15.8M.
  • Lam Research made up 0.69% of AGF Investments Inc's portfolio in Q3 2022, its #44 holding.
  • AGF Investments Inc first reported a position in Lam Research in Q4 2016 and has held it in 13 quarters since.
  • AGF Investments Inc's Lam Research position peaked at $125M in Q4 2021.
  • 1,271 funds tracked by Wall St. Rank held Lam Research as of Q3 2022.

Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.